Organization

Erik Allen Jensen

1 clinical trial

Clinical trial
Phase 1 Feasibility Trial of Inhaled Tobramycin in Preterm Infants With Bronchopulmonary Dysplasia
Status: Active (not recruiting), Estimated PCD: 2023-12-31